CNY 14.89
(-3.81%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 58 Million | 135.32 Million | 30.63 Million | 81.41 Million | 93.23 Million | 68.31 Million |
Net Income | 27.78 Million | 58.96 Million | 180.4 Million | 107.53 Million | 86.57 Million | 67.64 Million |
Depreciation & Amortization | 1.08 Million | 18.89 Million | 15.49 Million | 9.92 Million | 9.48 Million | 7.63 Million |
Deferred income taxes | -2.27 Million | 1.42 Million | -974.53 Thousand | -398.9 Thousand | 22.8 Thousand | -291.8 Thousand |
Stock-based compensation | - | - | - | - | - | 15.8 Million |
Change in working capital | -3.14 Million | 64.23 Million | -173.64 Million | -43.09 Million | -9.2 Million | -21.28 Million |
Other non-cash items | -2.03 Million | -6.77 Million | 8.38 Million | 7.04 Million | 6.37 Million | 14.31 Million |
Investing Cash Flow | -64.6 Million | -30.06 Million | -64.99 Million | -71 Million | -29.17 Million | -35.68 Million |
Investments in PPE | -85.27 Million | -10.32 Million | -73.82 Million | -72.13 Million | -41.58 Million | -26.03 Million |
Acquisitions | 8950.00 | 1.15 Million | 9.83 Million | 113.54 Thousand | 43.21 Million | 26.25 Million |
Investment purchases | - | - | - | -10 Million | -53.47 Million | -22.9 Million |
Sales/Maturities of investments | - | - | - | 10.01 Million | 64.25 Million | 13.03 Million |
Other Investing Activities | 20.65 Million | -20.89 Million | -1 Million | 1 Million | -41.58 Million | -26.03 Million |
Financing Cash Flow | -26 Million | -100 Million | 482.2 Million | -29.44 Million | -26.88 Million | 16.36 Million |
Debt repayment | - | - | -1 Million | -1 Million | -1 Million | -1 Million |
Dividends payments | -26 Million | -100 Million | -8991.66 | -25.03 Million | -25.04 Million | -61.48 Thousand |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | -29.14 Million | - | - | - |
Other Financing Activities | - | - | 482.2 Million | -3.41 Million | -840 Thousand | 17.42 Million |
Accounts receivables | -26.5 Million | 139.79 Million | -167.12 Million | -56.11 Million | -9.3 Million | -8.63 Million |
Accounts payables | 2.63 Million | -70.55 Million | 73.61 Million | 14.37 Million | -2.01 Million | -6.4 Million |
Inventory | 22.99 Million | -6.43 Million | -79.16 Million | -951.63 Thousand | 2.09 Million | -5.95 Million |
Other working capital | 365.14 Thousand | 1.42 Million | -974.53 Thousand | -398.85 Thousand | 22.78 Thousand | -15.33 Million |
Cash at beginning of period | 576.61 Million | 562.54 Million | 116.33 Million | 137.68 Million | 100.92 Million | 47.67 Million |
Cash at end of period | 546.31 Million | 576.61 Million | 562.54 Million | 116.33 Million | 137.68 Million | 100.92 Million |
Capital Expenditure | -85.27 Million | -10.32 Million | -73.82 Million | -72.13 Million | -41.58 Million | -26.03 Million |
Effect of forex changes on cash | 2.3 Million | 8.81 Million | -1.63 Million | -2.31 Million | -413.21 Thousand | 4.26 Million |
Net cash flow / Change in cash | -30.3 Million | 14.07 Million | 446.21 Million | -21.35 Million | 36.75 Million | 53.25 Million |
Free Cash Flow | -27.27 Million | 125 Million | -43.19 Million | 9.28 Million | 51.64 Million | 42.27 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 16.57 Million | 17.56 Million | 26.65 Thousand | 27.78 Million | 7.16 Million | 11.27 Million |
Depreciation & Amortization | 5.18 Million | 5.18 Million | 19.82 Million | 1.08 Million | -9.92 Million | 4.93 Million |
Deferred income taxes | - | - | - | -2.27 Million | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -3.5 Million | -3.14 Million | -7.11 Million | 7.11 Million |
Other non-cash items | 8.18 Million | -63.72 Million | -15.09 Million | -2.03 Million | 36.09 Million | 2.7 Million |
Investing Cash Flow | -22.57 Million | -39.98 Million | -55.18 Million | -64.6 Million | -3.42 Million | -407.22 Thousand |
Investments in PPE | -22.57 Million | -40.18 Million | -55.13 Million | -85.27 Million | -3.42 Million | -21.12 Million |
Acquisitions | - | 198 Thousand | 8950.00 | 8950.00 | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | 198 Thousand | -56 Thousand | 20.65 Million | - | 20.71 Million |
Financing Cash Flow | 10 Million | - | 321.2 Thousand | -26 Million | -1.71 Million | -24.61 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | -26 Million | -26 Million | -1.71 Million | -24.61 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | 26.32 Million | - | -1.71 Million | -24.61 Million |
Accounts receivables | - | - | -26.5 Million | -26.5 Million | 5.8 Million | -5.8 Million |
Accounts payables | - | - | - | 2.63 Million | - | - |
Inventory | - | - | 22.99 Million | 22.99 Million | -12.92 Million | 12.92 Million |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 460.22 Million | 546.31 Million | 600.41 Million | 576.61 Million | 578.86 Million | 575.13 Million |
Cash at end of period | 467.38 Million | 460.11 Million | 546.31 Million | 546.31 Million | 600.41 Million | 578.86 Million |
Capital Expenditure | -22.57 Million | -40.18 Million | -55.13 Million | -85.27 Million | -3.42 Million | -21.12 Million |
Effect of forex changes on cash | 162.56 Thousand | -50.27 Thousand | -484.56 Thousand | 2.3 Million | 464.46 Thousand | 2.72 Million |
Net cash flow / Change in cash | 7.15 Million | -86.19 Million | -54.09 Million | -30.3 Million | 21.55 Million | 3.73 Million |
Free Cash Flow | -3 Million | -86.34 Million | -53.88 Million | -27.27 Million | 22.79 Million | 4.9 Million |
WEGE3
HCMLF
ZYME
PRSK
600505
CNDT